EZH2 is often overexpressed in various cancers, including lymphoma, prostate cancer, and breast cancer, and UNC1999 works by restoring the expression of tumor-suppressor genes, thus inhibiting cancer cell proliferation [117, 118]. This evidence concerns the gene EZH2 and prostate cancer.